Skip to main content

Peer Review reports

From: Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model

Original Submission
19 Aug 2009 Submitted Original manuscript
24 Nov 2009 Reviewed Reviewer Report - Edgar Wood
30 Nov 2009 Reviewed Reviewer Report - Ken Olaussen
3 Dec 2009 Reviewed Reviewer Report - Helmout Modjtahedi
16 Feb 2010 Author responded Author comments - Alfonso Calvo
Resubmission - Version 2
16 Feb 2010 Submitted Manuscript version 2
17 Mar 2010 Reviewed Reviewer Report - Helmout Modjtahedi
18 Mar 2010 Reviewed Reviewer Report - Ken Olaussen
30 Mar 2010 Reviewed Reviewer Report - Edgar Wood
21 Apr 2010 Author responded Author comments - Alfonso Calvo
Resubmission - Version 3
21 Apr 2010 Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
3 May 2010 Author responded Author comments - Alfonso Calvo
Resubmission - Version 5
3 May 2010 Submitted Manuscript version 5
Publishing
11 May 2010 Editorially accepted
11 May 2010 Article published 10.1186/1471-2407-10-188

You can find further information about peer review here.

Back to article page